Immunovant Announces Redemption of Warrants and Achievement of First Earnout Milestone under Share Exchange AgreementGlobeNewsWire • 05/14/20
Immunovant Announces Closing of $139.4 Million Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional SharesGlobeNewsWire • 04/16/20